rs15336
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016270.4(KLF2):c.*171C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 602,548 control chromosomes in the GnomAD database, including 7,747 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1861 hom., cov: 32)
Exomes 𝑓: 0.15 ( 5886 hom. )
Consequence
KLF2
NM_016270.4 3_prime_UTR
NM_016270.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.53
Publications
7 publications found
Genes affected
KLF2 (HGNC:6347): (KLF transcription factor 2) This gene encodes a protein that belongs to the Kruppel family of transcription factors. The encoded zinc finger protein is expressed early in mammalian development and is found in many different cell types. The protein acts to bind the CACCC box found in the promoter of target genes to activate their transcription. It plays a role in many processes during development and disease including adipogenesis, embryonic erythropoiesis, epithelial integrity, inflammation and t-cell viability. [provided by RefSeq, Mar 2017]
KLF2 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 19-16327202-C-A is Benign according to our data. Variant chr19-16327202-C-A is described in ClinVar as Benign. ClinVar VariationId is 1182815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.151 AC: 22900AN: 152024Hom.: 1861 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
22900
AN:
152024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.150 AC: 67549AN: 450412Hom.: 5886 Cov.: 6 AF XY: 0.146 AC XY: 34243AN XY: 234954 show subpopulations
GnomAD4 exome
AF:
AC:
67549
AN:
450412
Hom.:
Cov.:
6
AF XY:
AC XY:
34243
AN XY:
234954
show subpopulations
African (AFR)
AF:
AC:
1530
AN:
11176
American (AMR)
AF:
AC:
1622
AN:
14780
Ashkenazi Jewish (ASJ)
AF:
AC:
1897
AN:
12242
East Asian (EAS)
AF:
AC:
325
AN:
28656
South Asian (SAS)
AF:
AC:
2361
AN:
40142
European-Finnish (FIN)
AF:
AC:
5759
AN:
28950
Middle Eastern (MID)
AF:
AC:
279
AN:
1860
European-Non Finnish (NFE)
AF:
AC:
50035
AN:
287746
Other (OTH)
AF:
AC:
3741
AN:
24860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
2762
5523
8285
11046
13808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.151 AC: 22905AN: 152136Hom.: 1861 Cov.: 32 AF XY: 0.150 AC XY: 11153AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
22905
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
11153
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
5505
AN:
41508
American (AMR)
AF:
AC:
1953
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
521
AN:
3468
East Asian (EAS)
AF:
AC:
36
AN:
5174
South Asian (SAS)
AF:
AC:
301
AN:
4828
European-Finnish (FIN)
AF:
AC:
2332
AN:
10582
Middle Eastern (MID)
AF:
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11727
AN:
67980
Other (OTH)
AF:
AC:
326
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
968
1936
2903
3871
4839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
154
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.